Abstract
Aldosterone synthase (CYP11B2) is responsible for the final step in aldosterone synthesis and is importantly regulated by angiotensin-II (Ang II) through diverse pathways. However, under pathological conditions, such as in hyperaldosteronism, the regulation becomes disordered. The transcription factor steroidogenic factor-1 (SF-1) is important in regulating the endocrine system and is overexpressed in aldosterone-producing adenoma (APA), a common cause of hyperaldosteronism. Overexpression of SF-1 has been extensively studied, but little in-depth information is available regarding the effects of inhibitory SF-1 on CYP11B2 and Ang II. In this paper, we have investigated the roles of down-regulated SF-1 in basal and Ang II-induced CYP11B2 expression using SF-1-specific short hairpin RNA. Inhibitory SF-1 was found to decrease the sensitivity of CYP11B2 and aldosterone to Ang II stimulation, whereas a down-regulation of SF-1 enhanced basal CYP11B2 expression and aldosterone production in H295R cells. Considering these differential effects of SF-1 on aldosterone production, these results might provide a new insight into the understanding of hyperaldosteronism.
Similar content being viewed by others
References
Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann NY Acad Sci 2002, 970: 89–100.
Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008, 19: 88–90.
Fallo F, Federspil G, Veglio F, Mulatero P. The metabolic syndrome in primary aldosteronism. Curr Diab Rep 2008, 8: 42–7.
Young WF Jr. Minireview: primary aldosteronism—changing concepts in diagnosis and treatment. Endocrinology 2003, 144: 2208–13.
LeHoux JG, Martel D, LeHoux J, Ducharme L, Lefebvre A, Brière N. P450aldo in hamster adrenal cortex: immunofluorescent and immuno-gold electron microscopic studies. Endocr Res 1995, 21: 275–80.
Pascoe L, Curnow KM. Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids 1995, 60: 22–7.
Beuschlein F, Keegan CE, Bavers DL, et al. SF-1, DAX-1, and acd: molecular determinants of adrenocortical growth and steroidogenesis. Endocr Res 2002, 28: 597–607.
Fowkes RC, Burrin JM. Steroidogenic factor-1: a key regulator of gonadotroph gene expression. J Endocrinol 2003, 177: 345–50.
Doghman M, Karpova T, Rodrigues GA, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007, 21: 2968–87.
Peter M, Dubuis JM. Transcription factors as regulators of steroidogenic P-450 enzymes. Eur J Clin Invest 2000, 30(Suppl 3): 14–20.
Bakke M, Lund J. Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 3′,5′-monophosphate-responsive sequence in the bovine CYP17 gene. Mol Endocrinol 1995, 9: 327–39.
Michael MD, Kilgore MW, Morohashi K, Simpson ER. Ad4bp/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 1995, 270: 13561–6.
Wang XL, Bassett M, Zhang Y, et al. Transcriptional regulation of human 11 beta-hydroxylase (hCYP11B1). Endocrinology 2000, 141: 3587–94.
Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11 beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002, 28: 125–35.
Ye P, Nakamura Y, Lalli E, Rainey WE. Differential effects of high and low steroidogenicfactor-1 expression on CYP11 B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009, 150: 1303–9.
Nogueira EF, Vargas CA, Otis M, Gallo-Payet N, Bollag WB, Rainey WE. Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J Mol Endocrinol 2007, 39: 365–74.
Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 1993, 7: 852–60.
Morohashi KI. Gonadal and extragonadal functions of Ad4BP/SF-1: developmental aspects. Trends Endocrinol Metab 1999, 10: 169–73.
Tsuchiya Y, Nakajima M, Takagi S, et al. Binding of steroidogenic factor-1 to the regulatory region might not be critical for transcriptional regulation of the human CYP1 B1 gene. J Biochem 2006, 139: 527–34.
Lefrançois-Martinez AM, Bertherat J, Val P, et al. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1 B1) is associated with malignancy in human sporadic adrenocortical tumors. J Clin Endocrinol Metab 2004, 89: 3010–9.
Hoivik EA, Aumo L, Aesoy R, et al. Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1. Endocrinology 2008, 149: 5599–609.
Mukai K, Mitani F, Shimada H, Ishimura Y. Involvement of an AP-1 complex in zone-specific expression of the CYP11B1 gene in the rat adrenal cortex. Mol Cell Biol 1995, 15: 6003–12.
Rainey WE. Adrenal zonation: clues from 11 beta-hydroxylase and aldosterone synthase. Mol Cell Endocrinol 1999, 151: 151–60.
Chen M, Hornsby PJ. Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells. Horm Metab Res 2006, 38: 549–55.
Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 2004, 18: 279–90.
Caron KM, Ikeda Y, Soo SC, Stocco DM, Parker KL, Clark BJ. Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory (StAR) Protein. Mol Endocrinol 1997, 11: 136–47.
Ito M, Yu RN, Jameson JL. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol Endocrinol 1998, 12: 290–301.
Børud B, Hoang T, Bakke M, Jacob AL, Lund J, Mellgren G. The nuclear receptor coactivators p300/CB P/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol Endocrinol 2002, 16: 757–73.
Hiroi N, Kino T, Bassett M, et al. Pituitary homeobox factor 1, a novel transcription factor in the adrenal regulating steroid 11 beta-hydroxylase. Horm Metab Res 2003, 35: 273–8.
Kelly SN, McKenna TJ, Young LS. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex. J Endocrinol 2005, 186: 33–42.
Hammer GD, Parker KL, Schimmer BP. Minireview: transcriptional regulation of adrenocortical development. Endocrinology 2005, 146: 1018–24.
Author information
Authors and Affiliations
Corresponding author
Additional information
J.O., D.H., B.W. contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ouyang, J., Hu, D., Wang, B. et al. Differential effects of down-regulated steroidogenic factor-1 on basal and angiotensin II-induced aldosterone secretion. J Endocrinol Invest 34, 671–675 (2011). https://doi.org/10.3275/7413
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/7413